Elevance Health Executive Compensation (FY25)
ELV · Executive and director compensation, fiscal 2022 to 2025
The paid brief on Elevance Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (8-K): May 13, 2026
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
319 figures on this page: 308 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
More on Elevance Health
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Gail Boudreaux: $20,471,976 → $22,582,314 (10.3% higher)
Say-on-pay support: 91.8% → 96.0% (4.2 points higher)
CEO pay ratio: 370:1 → 286:1 (22.7% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Elevance Health's chief executive and what were they paid?
Gail Boudreaux was paid $22,582,314 in total compensation as President and Chief Executive Officer for fiscal 2025. Boudreaux's total was 10.3% higher than the $20,471,976 reported for fiscal 2024.
What was Elevance Health's say-on-pay result?
The say-on-pay proposal drew 96.0% of votes cast for or against in favor at the meeting held May 13, 2026 for fiscal 2025.
Which companies are in Elevance Health's peer group?
The disclosed peer group names Centene Corporation, Chevron Corporation, Citigroup Inc., Comcast Corporation and Costco Wholesale Corporation, among others. The General Industry Group names Alphabet Inc., Amazon.com, Inc., Apple Inc., Archer-Daniels-Midland Company and AT&T Inc., among others.
What is Elevance Health's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 286:1, against median employee compensation of $79,007.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Gail Boudreaux President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Gallina Former Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Peter Haytaian Executive Vice President and President of Carelon and CarelonRx | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Felicia Norwood Executive Vice President and President of Government Health Benefits | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Gail Boudreaux President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Mark Kaye Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
John Gallina Former Executive Vice President and Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ |
Blair Todt Executive Vice President, Chief Legal and Administrative Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Peter Haytaian Executive Vice President and President of Carelon and CarelonRx | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Felicia Norwood Executive Vice President and President of Government Health Benefits | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Gail Boudreaux President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Mark Kaye Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Peter Haytaian Executive Vice President and President of Carelon and CarelonRx | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Felicia Norwood Executive Vice President and President of Government Health Benefits | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Morgan Kendrick Executive Vice President and President of Commercial and Specialty Health Benefits | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Gail Boudreaux President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Mark Kaye Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Peter Haytaian Executive Vice President and President of Carelon and CarelonRx | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Felicia Norwood Executive Vice President and President of Government Health Benefits | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
C. Morgan Kendrick Executive Vice President and President of Commercial and Specialty Health Benefits | ◇ | — | ◇ | ◇ | ◇ | ◇ | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| C. Morgan Kendrick | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| C. Morgan Kendrick | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
| C. Morgan Kendrick | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Felicia Norwood | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Felicia Norwood | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Felicia Norwood | PSU | ◇ | — | — | — | — | — | ◇ |
| Gail Boudreaux | PSU | ◇ | — | — | — | — | — | ◇ |
| Gail Boudreaux | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Gail Boudreaux | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Mark Kaye | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Mark Kaye | PSU | ◇ | — | — | — | — | — | ◇ |
| Mark Kaye | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Peter Haytaian | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Peter Haytaian | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Peter Haytaian | PSU | ◇ | — | ◇ | — | ◇ | — | ◇ |
Fiscal 2023 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Mark Kaye | Option | ◇ | — | ◇ | — |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| Morgan Kendrick | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Felicia Norwood | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — | |
| Peter Haytaian | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Gail Boudreaux | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Ramiro G. Peru Board chair | ◇ | ◇ | — | — | — | ◇ | ◇ |
Elizabeth E. Tallett | ◇ | ◇ | — | — | — | — | ◇ |
Ryan M. Schneider | ◇ | ◇ | — | — | — | ◇ | ◇ |
Bahija Jallal | ◇ | ◇ | — | — | — | ◇ | ◇ |
Antonio F. Neri | ◇ | ◇ | — | — | — | ◇ | ◇ |
Susan D. DeVore | ◇ | ◇ | — | — | — | ◇ | ◇ |
R. Kerry Clark | ◇ | ◇ | — | — | — | ◇ | ◇ |
Robert L. Dixon Jr | ◇ | ◇ | — | — | — | ◇ | ◇ |
Deanna D. Strable | ◇ | ◇ | — | — | — | ◇ | ◇ |
Lewis Hay III | ◇ | ◇ | — | — | — | ◇ | ◇ |
Steven H. Collis | ◇ | ◇ | — | — | — | ◇ | ◇ |
Gail K. Boudreaux and Amy W. Schulman served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as deferred stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Centene Corporation CNC
- Chevron Corporation CVX
- Citigroup Inc. C
- Comcast Corporation CMCSA
- Costco Wholesale Corporation COST
- CVS Health Corporation CVS
- Dell Technologies Inc. DELL
- Exxon Mobil Corporation XOM
- Federal Home Loan Mortgage Corporation FMCC
- Federal National Mortgage Association FNMA
- FedEx Corporation FDX
- Ford Motor Company F
- General Motors Company GM
- Humana Inc. HUM
- Johnson & Johnson JNJ
- JPMorgan Chase & Co. JPM
- Lowe's Companies, Inc. LOW
- Marathon Petroleum Corporation MPC
- McKesson Corporation MCK
- Meta Platforms, Inc. META
- Microsoft Corporation MSFT
- Morgan Stanley MS
- PepsiCo, Inc. PEP
- Phillips 66 PSX
- Target Corporation TGT
- Tesla, Inc. TSLA
- The Cigna Group CI
- The Goldman Sachs Group, Inc. GS
- The Home Depot, Inc. HD
- The Kroger Co. KR
- The Procter & Gamble Company PG
- The Walt Disney Company DIS
- United Parcel Service, Inc. UPS
- UnitedHealth Group Incorporated UNH
- Valero Energy Corporation VLO
- Verizon Communications Inc. VZ
- Walgreens Boots Alliance, Inc. WBA
- Walmart Inc. WMT
- Wells Fargo & Company WFC
General Industry Group
- Alphabet Inc. GOOGL
- Amazon.com, Inc. AMZN
- Apple Inc. AAPL
- Archer-Daniels-Midland Company ADM
- AT&T Inc. T
- Bank of America Corporation BAC
- Berkshire Hathaway Inc. BRK.A
- Cardinal Health, Inc. CAH
- Cencora, Inc. COR
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 13, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 14, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 15, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 10, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 18, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 26, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 21, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 15, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 16, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 18, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | May 19, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Elevance Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Elevance Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
319 figures on this page: 308 cited to the filing that reported them, 11 calculated from figures it prints.
308 cited to the filing
11 calculated from the filing
Documents cited
- 0001156039-26-000046Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001156039-26-000031CEO Pay Ratio · Compensation of Non-Employee Directors · Grants of Plan-Based Awards · Outstanding Equity Awards at Fiscal Year-End · and 1 more section
- 0001156039-25-000065
- 0001156039-24-000069
- 0001156039-24-000050Summary Compensation Table
- 0001156039-23-000067
- 0001156039-23-000050Summary Compensation Table
- 0001193125-22-154417
- 0001193125-21-175381
- 0001193125-20-148721
- 0001193125-19-147906Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-18-165264
- 0001193125-17-175313Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-16-597089Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001156039-25-000046Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Elevance Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ELV (accessed 2026).
Short form: data: Velarion
The paid brief for Elevance Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Elevance Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Elevance Health discloses
The companies named in ELV's own disclosed peer group.
Centene CorporationChevron CorporationCitigroup Inc.Comcast CorporationCostco Wholesale CorporationCVS Health CorporationDell Technologies Inc.Exxon Mobil CorporationFedEx CorporationFord Motor CompanyGeneral Motors CompanyHumana Inc.Johnson & JohnsonJPMorgan Chase & Co.Lowe's Companies, Inc.Marathon Petroleum CorporationMcKesson CorporationMeta Platforms, Inc.Microsoft CorporationMorgan StanleyPepsiCo, Inc.Phillips 66Target CorporationTesla, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}